Back
Novavax Quote, Financials, Valuation and Earnings
Sponsored
NVAX
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
25
NVAX
Novavax
Last Price:
$8.72
Seasonality Move:
7.22%
7 Day Trial
ALL ACCESS PASS
$
7
The 7 new tech giants dominating today's markets
Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.Novavax Price Quote
$8.72
+0.01 (+0.46%)
(Updated: December 21, 2024 at 5:39 AM ET)
Novavax Key Stats
Sell
25
Novavax (NVAX)
is a Sell
Day range:
$8.37 - $8.89
52-week range:
$3.53 - $23.86
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.52
P/B ratio:
0%
Volume:
6.1M
Avg. volume:
4.9M
1-year change:
77.49%
Market cap:
$1.4B
Revenue:
$556.4M
EPS:
$-2.29
How Much Does Novavax Make?
Data Unavailable
Is Novavax Growing As A Company?
Data Unavailable
Novavax Stock Price Performance
What Is Novavax 52-Week High & Low?
Novavax Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Novavax?
Data Unavailable
Is Novavax Cash Flow Positive?
Data Unavailable
Novavax Return On Invested Capital
Data Unavailable
Novavax Earnings Date & Stock Price
-
What Is Novavax's Stock Price Today?A single share of NVAX can be purchased today for 8.72
-
What Is Novavax’s Stock Symbol?
-
When Is Novavax’s Next Earnings Date?The next quarterly earnings date for Novavax is scheduled on February 28, 2025
-
When Is NVAX's next ex-dividend date?Novavax's next ex-dividend date is December 22, 2024
-
How To Buy Novavax Stock?You can buy Novavax shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Novavax Competitors
Novavax Dividend Yield
Data Unavailable
Novavax Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 70.69% | -1.88% |
Revenue: | 283.03% | 14.58% |
Analyst Recommendations
Buy Recommendations: | 2 |
---|---|
Hold Recommendations: | 2 |
Sell Recommendations: | 0 |
Price Target: | 16.00 |
Upside from Last Price: | 83.59% |
Major Shareholders
Data Unavailable